---
schema_version: "secwatch.filing_event.v1"
accession: "0001005286-24-000169"
form_type: "8-K"
ticker: "LFCR"
cik: "0001005286"
company_name: "LIFECORE BIOMEDICAL, INC. DE"
filed_at: "2024-11-26T23:59:59+00:00"
generated_at: "2026-05-29T17:26:41.301636+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Lifecore extends BMO revolving credit facility to Nov 2027, lowers rates

## Summary
- Maturity extended three years to November 2027 under BMO ABL facility.
- Interest rates simplified and reduced; no fees paid for amendments.
- Alcon term loan covenants aligned with BMO facility via separate amendment.
- Follows $24.3M PIPE financing; company says balance sheet strengthened.
- CEO cites BMO confidence and recent customer wins including Lindy Biosciences.

## SEC filing metadata
- accession: 0001005286-24-000169
- form_type: 8-K
- ticker: LFCR
- cik: 0001005286
- company_name: LIFECORE BIOMEDICAL, INC. DE
- filed_at: 2024-11-26T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000169/0001005286-24-000169-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000169/lndc-20241126.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001005286-24-000169
- JSON: https://secwatch.observer/filing/0001005286-24-000169.json
- Plain text: https://secwatch.observer/filing/0001005286-24-000169.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.